Answers are grounded in this paper and cite their sources.
Introduction Severe fever with thrombocytopenia syndrome virus (SFTSV), a novel bunyavirus associated with febrile illness, thrombocytopenia, and leukopenia, represents a considerable public health threat. Methods In this study, we developed a visual detection platform for SFTSV by integrating reverse transcription-recombinase polymerase amplification (RT-RPA) with lateral flow nucleic acid chromatography assay (LFNA). The method operates under isothermal conditions, and delivers results within 40 minutes. Using a conserved region of the S segment as the amplification target. Results The assay demonstrated a detection limit of 10 1 copies/μL and showed no cross-reactivity with 12 other common clinical pathogens or 6 less common clinical pathogens. An evaluation of 80 SFTSV-positive clinical samples and 16 SFTSV-negative clinical samples showed that, compared with quantitative PCR (qPCR), the method demonstrated excellent sensitivity and specificity. Discussion The RT-RPA-LFNA platform is easy to operate, provides rapid results and is cost-effective, and therefore has potential for use in point-of-care testing (POCT), particularly in resource-limited primary healthcare settings. This approach not only provides a reliable tool for SFTSV diagnosis but also holds potential for the detection of other pathogens.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: